Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-23

Clinical Trial Update: Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System

View source ↗

Summary

This clinical trial evaluated the accuracy of Abbott's sensor-based interstitial glucose monitoring system in individuals with Type 1 diabetes mellitus and Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abbott Sensor-Based Interstitial Glucose Monitoring System

Snippet

Sponsor: Abbott Diabetes Care | Conditions: Type 1 Diabetes, Type 2 Diabetes | Status: COMPLETED